retatrutide ly3437943 triple agonist gip glp-1 glucagon peptide LY3437943 in healthy participants in

Adipogen Life Sciences

A new deal may cut the cost of weight-loss drugs, but this UVA professor warns of potential long-term risks.

Researchers are examining whether drugs currently approved to treat obesity and type 2 diabetes could be useful for a wider range of health challenges.

Molecular communications in the gutbrain axis, between the central nervous system and the gastrointestinal tract, are critical for maintaining healthy brain function, particularly in aging

While our current treatments have shown significant therapeutic benefits, there still appear to be some patients who, despite aggressive therapy, good adherence, and inhaler technique, continue to have exacerbations

Using Brandwatch I analyzed around 150K Reddit posts across communities like r/Zepbound, r/Ozempic, r/WegovyWeightLoss, r/Mounjaro, and r/Semaglutide